Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Invest Ophthalmol Vis Sci

Retrieve available abstracts of 122 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KALTENIECE A, Ferdousi M, Azmi S, Marshall A, et al
    Keratocyte Density Is Reduced and Related to Corneal Nerve Damage in Diabetic Neuropathy.
    Invest Ophthalmol Vis Sci. 2018;59:3584-3590.
    PubMed     Text format     Abstract available


    June 2018
  2. SANDHU HS, Eltanboly A, Shalaby A, Keynton RS, et al
    Automated Diagnosis and Grading of Diabetic Retinopathy Using Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2018;59:3155-3160.
    PubMed     Text format     Abstract available


    May 2018
  3. LU Y, Simonett JM, Wang J, Zhang M, et al
    Evaluation of Automatically Quantified Foveal Avascular Zone Metrics for Diagnosis of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2018;59:2212-2221.
    PubMed     Text format     Abstract available


  4. GALE JD, Berger B, Gilbert S, Popa S, et al
    A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:2659-2669.
    PubMed     Text format     Abstract available


  5. MCANANY JJ, Park JC
    Reduced Contrast Sensitivity is Associated With Elevated Equivalent Intrinsic Noise in Type 2 Diabetics Who Have Mild or No Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2652-2658.
    PubMed     Text format     Abstract available


  6. LIM RR, Grant DG, Olver TD, Padilla J, et al
    Young Ossabaw Pigs Fed a Western Diet Exhibit Early Signs of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2325-2338.
    PubMed     Text format     Abstract available


  7. SUNDSTROM JM, Hernandez C, Weber SR, Zhao Y, et al
    Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases.
    Invest Ophthalmol Vis Sci. 2018;59:2264-2274.
    PubMed     Text format     Abstract available


    April 2018
  8. CHEN Q, Tan F, Wu Y, Zhuang X, et al
    Characteristics of Retinal Structural and Microvascular Alterations in Early Type 2 Diabetic Patients.
    Invest Ophthalmol Vis Sci. 2018;59:2110-2118.
    PubMed     Text format     Abstract available


  9. NAHOMI RB, Sampathkumar S, Myers AM, Elghazi L, et al
    The Absence of Indoleamine 2,3-Dioxygenase Inhibits Retinal Capillary Degeneration in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:2042-2053.
    PubMed     Text format     Abstract available


  10. LEI J, Yi E, Suo Y, Chen C, et al
    Distinctive Analysis of Macular Superficial Capillaries and Large Vessels Using Optical Coherence Tomographic Angiography in Healthy and Diabetic Eyes.
    Invest Ophthalmol Vis Sci. 2018;59:1937-1943.
    PubMed     Text format     Abstract available


  11. LUO XY, Tan NYQ, Chee ML, Shi Y, et al
    Direct and Indirect Associations Between Diabetes and Intraocular Pressure: The Singapore Epidemiology of Eye Diseases Study.
    Invest Ophthalmol Vis Sci. 2018;59:2205-2211.
    PubMed     Text format     Abstract available


  12. ONISHI AC, Nesper PL, Roberts PK, Moharram GA, et al
    Importance of Considering the Middle Capillary Plexus on OCT Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:2167-2176.
    PubMed     Text format     Abstract available


    March 2018
  13. SCHORI C, Trachsel C, Grossmann J, Zygoula I, et al
    The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:AMD31-AMD40.
    PubMed     Text format     Abstract available


  14. GLASSMAN AR, Liu D, Jampol LM, Sun JK, et al
    Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:1199-1205.
    PubMed     Text format     Abstract available


    February 2018
  15. DELIYANTI D, Alrashdi SF, Tan SM, Meyer C, et al
    Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:815-825.
    PubMed     Text format     Abstract available


  16. LEE H, Jang H, Choi YA, Kim HC, et al
    Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:715-721.
    PubMed     Text format     Abstract available


  17. CHEN H, Zhang X, Liao N, Mi L, et al
    Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2018;59:978-985.
    PubMed     Text format     Abstract available


  18. CHEN X, Graham J, Petropoulos IN, Ponirakis G, et al
    Corneal Nerve Fractal Dimension: A Novel Corneal Nerve Metric for the Diagnosis of Diabetic Sensorimotor Polyneuropathy.
    Invest Ophthalmol Vis Sci. 2018;59:1113-1118.
    PubMed     Text format     Abstract available


    January 2018
  19. WHITCUP SM, Cidlowski JA, Csaky KG, Ambati J, et al
    Pharmacology of Corticosteroids for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2018;59:1-12.
    PubMed     Text format     Abstract available


  20. KIM MK, Aung MH, Mees L, Olson DE, et al
    Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2018;59:572-581.
    PubMed     Text format     Abstract available


  21. ABRAMOFF MD, Fort PE, Han IC, Jayasundera KT, et al
    Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2018;59:519-527.
    PubMed     Text format     Abstract available


    December 2017
  22. STUARD WL, Titone R, Robertson DM
    Tear Levels of Insulin-Like Growth Factor Binding Protein 3 Correlate With Subbasal Nerve Plexus Changes in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:6105-6112.
    PubMed     Text format     Abstract available


  23. LAGALI NS, Allgeier S, Guimaraes P, Badian RA, et al
    Reduced Corneal Nerve Fiber Density in Type 2 Diabetes by Wide-Area Mosaic Analysis.
    Invest Ophthalmol Vis Sci. 2017;58:6318-6327.
    PubMed     Text format     Abstract available


  24. GUYON B, Elphege E, Flores M, Gauthier AS, et al
    Retinal Reflectivity Measurement for Cone Impairment Estimation and Visual Assessment After Diabetic Macular Edema Resolution (RECOVER-DME).
    Invest Ophthalmol Vis Sci. 2017;58:6241-6247.
    PubMed     Text format     Abstract available


  25. DURAISAMY AJ, Mishra M, Kowluru RA
    Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:6440-6448.
    PubMed     Text format     Abstract available


  26. FENWICK EK, Khadka J, Pesudovs K, Rees G, et al
    Diabetic Retinopathy and Macular Edema Quality-of-Life Item Banks: Development and Initial Evaluation Using Computerized Adaptive Testing.
    Invest Ophthalmol Vis Sci. 2017;58:6379-6387.
    PubMed     Text format     Abstract available


  27. SRINIVASAN S, Dehghani C, Pritchard N, Edwards K, et al
    Corneal and Retinal Neuronal Degeneration in Early Stages of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:6365-6373.
    PubMed     Text format     Abstract available


  28. ZHANG SJ, Chen X, Li CP, Li XM, et al
    Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:6500-6509.
    PubMed     Text format     Abstract available


  29. MITCHELL SL, Neininger AC, Bruce CN, Chocron IM, et al
    Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:6481-6488.
    PubMed     Text format     Abstract available


    November 2017
  30. WEI Q, Zhang T, Jiang R, Chang Q, et al
    Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
    Invest Ophthalmol Vis Sci. 2017;58:5783-5791.
    PubMed     Text format     Abstract available


  31. DODO Y, Murakami T, Suzuma K, Yoshitake S, et al
    Diabetic Neuroglial Changes in the Superficial and Deep Nonperfused Areas on Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2017;58:5870-5879.
    PubMed     Text format     Abstract available


  32. SRINIVASAN S, Raman R, Swaminathan G, Ganesan S, et al
    Incidence, Progression, and Risk Factors for Cataract in Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5921-5929.
    PubMed     Text format     Abstract available


  33. HWANG HS, Chae JB, Kim JY, Kim DY, et al
    Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Invest Ophthalmol Vis Sci. 2017;58:5958-5967.
    PubMed     Text format     Abstract available


    October 2017
  34. OMAE T, Nagaoka T, Yoshida A
    Effect of Circulating Omentin-1 on the Retinal Circulation in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:5086-5092.
    PubMed     Text format     Abstract available


  35. HU P, Hunt NH, Arfuso F, Shaw LC, et al
    Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Muller Cells of Diabetic Human and Rodent Retina.
    Invest Ophthalmol Vis Sci. 2017;58:5043-5055.
    PubMed     Text format     Abstract available


  36. DENG G, Moran EP, Cheng R, Matlock G, et al
    Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5030-5042.
    PubMed     Text format     Abstract available


  37. BOSS JD, Singh PK, Pandya HK, Tosi J, et al
    Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5594-5603.
    PubMed     Text format     Abstract available


  38. BLAIR NP, Wanek J, Felder AE, Joslin CE, et al
    Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:5556-5563.
    PubMed     Text format     Abstract available


  39. HAFNER J, Ginner L, Karst S, Leitgeb R, et al
    Regional Patterns of Retinal Oxygen Saturation and Microvascular Hemodynamic Parameters Preceding Retinopathy in Patients With Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5541-5547.
    PubMed     Text format     Abstract available


    September 2017
  40. DI G, Qi X, Zhao X, Zhang S, et al
    Corneal Epithelium-Derived Neurotrophic Factors Promote Nerve Regeneration.
    Invest Ophthalmol Vis Sci. 2017;58:4695-4702.
    PubMed     Text format     Abstract available


  41. FERNANDEZ-BUENO I, Jones R, Soriano-Romani L, Lopez-Garcia A, et al
    Histologic Characterization of Retina Neuroglia Modifications in Diabetic Zucker Diabetic Fatty Rats.
    Invest Ophthalmol Vis Sci. 2017;58:4925-4933.
    PubMed     Text format     Abstract available


  42. KAIZU Y, Nakao S, Yoshida S, Hayami T, et al
    Optical Coherence Tomography Angiography Reveals Spatial Bias of Macular Capillary Dropout in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:4889-4897.
    PubMed     Text format     Abstract available


  43. BRAZIER J, Muston D, Konwea H, Power GS, et al
    Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
    Invest Ophthalmol Vis Sci. 2017;58:4818-4825.
    PubMed     Text format     Abstract available


    August 2017
  44. HAN WH, Gotzmann J, Kuny S, Huang H, et al
    Modifications in Retinal Mitochondrial Respiration Precede Type 2 Diabetes and Protracted Microvascular Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:3826-3839.
    PubMed     Text format     Abstract available


  45. HAJ NAJEEB B, Simader C, Deak G, Vass C, et al
    The Distribution of Leakage on Fluorescein Angiography in Diabetic Macular Edema: A New Approach to Its Etiology.
    Invest Ophthalmol Vis Sci. 2017;58:3986-3990.
    PubMed     Text format     Abstract available


  46. DI G, Du X, Qi X, Zhao X, et al
    Mesenchymal Stem Cells Promote Diabetic Corneal Epithelial Wound Healing Through TSG-6-Dependent Stem Cell Activation and Macrophage Switch.
    Invest Ophthalmol Vis Sci. 2017;58:4064-4074.
    PubMed     Text format     Abstract available


  47. MARIOTTI L, Devaney N, Lombardo G, Lombardo M, et al
    Analysis of Cone Mosaic Reflectance Properties in Healthy Eyes and in Eyes With Nonproliferative Diabetic Retinopathy Over Time.
    Invest Ophthalmol Vis Sci. 2017;58:4057-4067.
    PubMed     Text format     Abstract available


    July 2017
  48. SAWIDES L, Sapoznik KA, de Castro A, Walker BR, et al
    Alterations to the Foveal Cone Mosaic of Diabetic Patients.
    Invest Ophthalmol Vis Sci. 2017;58:3395-3403.
    PubMed     Text format     Abstract available


  49. CHEN Q, Ma Q, Wu C, Tan F, et al
    Macular Vascular Fractal Dimension in the Deep Capillary Layer as an Early Indicator of Microvascular Loss for Retinopathy in Type 2 Diabetic Patients.
    Invest Ophthalmol Vis Sci. 2017;58:3785-3794.
    PubMed     Text format     Abstract available


    June 2017
  50. GALAN A, Barcelona PF, Nedev H, Sarunic MV, et al
    Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2852-2862.
    PubMed     Text format     Abstract available


  51. TIEN T, Zhang J, Muto T, Kim D, et al
    High Glucose Induces Mitochondrial Dysfunction in Retinal Muller Cells: Implications for Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2915-2921.
    PubMed     Text format     Abstract available


  52. CAMMALLERI M, Locri F, Marsili S, Dal Monte M, et al
    The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood-Retinal Barrier Leakage in a Rat Model of Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:3138-3148.
    PubMed     Text format     Abstract available


  53. ABU EL-ASRAR AM, Struyf S, Mohammad G, Gouwy M, et al
    Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:3189-3201.
    PubMed     Text format     Abstract available


    May 2017
  54. LIEW G, Benitez-Aguirre P, Craig ME, Jenkins AJ, et al
    Progressive Retinal Vasodilation in Patients With Type 1 Diabetes: A Longitudinal Study of Retinal Vascular Geometry.
    Invest Ophthalmol Vis Sci. 2017;58:2503-2509.
    PubMed     Text format     Abstract available


  55. LIM LS, Ling LH, Ong PG, Foulds W, et al
    Dynamic Responses in Retinal Vessel Caliber With Flicker Light Stimulation and Risk of Diabetic Retinopathy and Its Progression.
    Invest Ophthalmol Vis Sci. 2017;58:2449-2455.
    PubMed     Text format     Abstract available


  56. LUO T, Gast TJ, Vermeer TJ, Burns SA, et al
    Retinal Vascular Branching in Healthy and Diabetic Subjects.
    Invest Ophthalmol Vis Sci. 2017;58:2685-2694.
    PubMed     Text format     Abstract available


  57. VUJOSEVIC S, Simo R
    Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach.
    Invest Ophthalmol Vis Sci. 2017;58:BIO68-BIO75.
    PubMed     Text format     Abstract available


  58. CHATZIRALLI I, Sergentanis TN, Crosby-Nwaobi R, Winkley K, et al
    Model for Risk-Based Screening of Diabetic Retinopathy in People With Newly-Diagnosed Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:BIO99-BIO105.
    PubMed     Text format     Abstract available


  59. KIM D, Mecham RP, Trackman PC, Roy S, et al
    Downregulation of Lysyl Oxidase Protects Retinal Endothelial Cells From High Glucose-Induced Apoptosis.
    Invest Ophthalmol Vis Sci. 2017;58:2725-2731.
    PubMed     Text format     Abstract available


  60. HASSAN I, Luo Q, Majumdar S, Dominguez JM 2nd, et al
    Tumor Necrosis Factor Alpha (TNF-alpha) Disrupts Kir4.1 Channel Expression Resulting in Muller Cell Dysfunction in the Retina.
    Invest Ophthalmol Vis Sci. 2017;58:2473-2482.
    PubMed     Text format     Abstract available


  61. LIM LS, Chee ML, Cheung CY, Wong TY, et al
    Retinal Vessel Geometry and the Incidence and Progression of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:BIO200-BIO205.
    PubMed     Text format     Abstract available


  62. CUNHA-VAZ J, Ribeiro L, Costa M, Simo R, et al
    Diabetic Retinopathy Phenotypes of Progression to Macular Edema: Pooled Analysis From Independent Longitudinal Studies of up to 2 Years' Duration.
    Invest Ophthalmol Vis Sci. 2017;58:BIO206-BIO210.
    PubMed     Text format     Abstract available


  63. DEHGHANI C, Srinivasan S, Edwards K, Pritchard N, et al
    Presence of Peripheral Neuropathy Is Associated With Progressive Thinning of Retinal Nerve Fiber Layer in Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:BIO234-BIO239.
    PubMed     Text format     Abstract available


  64. JOLTIKOV KA, de Castro VM, Davila JR, Anand R, et al
    Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:BIO277-BIO290.
    PubMed     Text format     Abstract available


  65. NESPER PL, Roberts PK, Onishi AC, Chai H, et al
    Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2017;58:BIO307-BIO315.
    PubMed     Text format     Abstract available


    April 2017
  66. OBARA EA, Hannibal J, Heegaard S, Fahrenkrug J, et al
    Loss of Melanopsin-Expressing Retinal Ganglion Cells in Patients With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2187-2192.
    PubMed     Text format     Abstract available


  67. ALDRICH BT, Schlotzer-Schrehardt U, Skeie JM, Burckart KA, et al
    Mitochondrial and Morphologic Alterations in Native Human Corneal Endothelial Cells Associated With Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:2130-2138.
    PubMed     Text format     Abstract available


  68. VANLANDINGHAM PA, Nuno DJ, Quiambao AB, Phelps E, et al
    Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2095-2105.
    PubMed     Text format     Abstract available


  69. SUN MH, Shariati MA, Liao YJ
    Experimental Anterior Ischemic Optic Neuropathy in Diabetic Mice Exhibited Severe Retinal Swelling Associated With VEGF Elevation.
    Invest Ophthalmol Vis Sci. 2017;58:2296-2305.
    PubMed     Text format     Abstract available


    March 2017
  70. ZHUANG P, Muraleedharan CK, Xu S
    Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model.
    Invest Ophthalmol Vis Sci. 2017;58:1646-1655.
    PubMed     Text format     Abstract available


  71. DIMITROVA G, Chihara E, Takahashi H, Amano H, et al
    Author Response: Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:1767.
    PubMed     Text format    


  72. TANG F, Cheung CY
    Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:1766.
    PubMed     Text format    


  73. GIOCANTI-AUREGAN A, Fajnkuchen F
    Author Response: Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Invest Ophthalmol Vis Sci. 2017;58:1857.
    PubMed     Text format    


  74. ASHRAF M
    Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Invest Ophthalmol Vis Sci. 2017;58:1856.
    PubMed     Text format    


    February 2017
  75. GIOCANTI-AUREGAN A, Hrarat L, Qu LM, Sarda V, et al
    Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Invest Ophthalmol Vis Sci. 2017;58:797-800.
    PubMed     Text format     Abstract available


  76. BREGMAN JA, Herren DJ, Estopinal CB, Chocron IM, et al
    Mitochondrial Haplogroups Affect Severity But Not Prevalence of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:1346-1351.
    PubMed     Text format     Abstract available


  77. LIU W, Wang S, Soetikno B, Yi J, et al
    Increased Retinal Oxygen Metabolism Precedes Microvascular Alterations in Type 1 Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2017;58:981-989.
    PubMed     Text format     Abstract available


  78. MASUDA T, Shimazawa M, Hashimoto Y, Kojima A, et al
    Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic Neovascularization.
    Invest Ophthalmol Vis Sci. 2017;58:1208-1217.
    PubMed     Text format     Abstract available


  79. SAMRA YA, Saleh HM, Hussein KA, Elsherbiny NM, et al
    Adenosine Deaminase-2-Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p.
    Invest Ophthalmol Vis Sci. 2017;58:933-943.
    PubMed     Text format     Abstract available


    January 2017
  80. THOMAS AA, Feng B, Chakrabarti S
    ANRIL: A Regulator of VEGF in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:470-480.
    PubMed     Text format     Abstract available


  81. DIMITROVA G, Chihara E, Takahashi H, Amano H, et al
    Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:190-196.
    PubMed     Text format     Abstract available


  82. GHASEMI FALAVARJANI K, Iafe NA, Hubschman JP, Tsui I, et al
    Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Invest Ophthalmol Vis Sci. 2017;58:30-34.
    PubMed     Text format     Abstract available


    December 2016
  83. DAS A
    Diabetic Retinopathy: Battling the Global Epidemic.
    Invest Ophthalmol Vis Sci. 2016;57:6669-6682.
    PubMed     Text format    


  84. LAMMER J, Prager SG, Cheney MC, Ahmed A, et al
    Cone Photoreceptor Irregularity on Adaptive Optics Scanning Laser Ophthalmoscopy Correlates With Severity of Diabetic Retinopathy and Macular Edema.
    Invest Ophthalmol Vis Sci. 2016;57:6624-6632.
    PubMed     Text format     Abstract available


  85. CUNHA-VAZ J, Santos T, Ribeiro L, Alves D, et al
    OCT-Leakage: A New Method to Identify and Locate Abnormal Fluid Accumulation in Diabetic Retinal Edema.
    Invest Ophthalmol Vis Sci. 2016;57:6776-6783.
    PubMed     Text format     Abstract available


  86. PARK JH, Kang SS, Kim JY, Tchah H, et al
    Nerve Growth Factor Attenuates Apoptosis and Inflammation in the Diabetic Cornea.
    Invest Ophthalmol Vis Sci. 2016;57:6767-6775.
    PubMed     Text format     Abstract available


  87. PRASAD T, Roksnoer LC, Zhu P, Verma A, et al
    Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
    Invest Ophthalmol Vis Sci. 2016;57:6722-6730.
    PubMed     Text format     Abstract available


    November 2016
  88. BLAIR NP, Wanek J, Felder AE, Brewer KC, et al
    Inner Retinal Oxygen Delivery, Metabolism, and Extraction Fraction in Ins2Akita Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2016;57:5903-5909.
    PubMed     Text format     Abstract available


  89. ISHIBAZAWA A, Nagaoka T, Yokota H, Takahashi A, et al
    Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:6247-6255.
    PubMed     Text format     Abstract available


  90. FICKWEILER W, Klaassen I, Vogels IM, Hooymans JM, et al
    Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial.
    Invest Ophthalmol Vis Sci. 2016;57:6234-6241.
    PubMed     Text format     Abstract available


  91. TAVARES FERREIRA J, Alves M, Dias-Santos A, Costa L, et al
    Retinal Neurodegeneration in Diabetic Patients Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:6455-6460.
    PubMed     Text format     Abstract available


    October 2016
  92. ABRAMOFF MD, Lou Y, Erginay A, Clarida W, et al
    Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning.
    Invest Ophthalmol Vis Sci. 2016;57:5200-5206.
    PubMed     Text format     Abstract available


  93. ZHANG M, Hwang TS, Dongye C, Wilson DJ, et al
    Automated Quantification of Nonperfusion in Three Retinal Plexuses Using Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5101-5106.
    PubMed     Text format     Abstract available


  94. NAIR P, Aiello LP, Gardner TW, Jampol LM, et al
    Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.
    Invest Ophthalmol Vis Sci. 2016;57:5127-5142.
    PubMed     Text format    


  95. EL-FAYOUMI D, Badr Eldine NM, Esmael AF, Ghalwash D, et al
    Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses Are Reduced in Children With Type 1 Diabetes With No Evidence of Vascular Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5355-5360.
    PubMed     Text format     Abstract available


  96. GUDURU A, Martz TG, Waters A, Kshirsagar AV, et al
    Oxygen Saturation of Retinal Vessels in All Stages of Diabetic Retinopathy and Correlation to Ultra-Wide Field Fluorescein Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:5278-5284.
    PubMed     Text format     Abstract available


  97. ARONEY C, Fraser-Bell S, Lamoureux EL, Gillies MC, et al
    Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2016;57:5541-5546.
    PubMed     Text format     Abstract available


  98. CHEUNG CY, Hui EY, Lee CH, Kwok KH, et al
    Impact of Genetic Loci Identified in Genome-Wide Association Studies on Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:5518-5524.
    PubMed     Text format     Abstract available


  99. FELDER AE, Wanek J, Blair NP, Joslin CE, et al
    The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction.
    Invest Ophthalmol Vis Sci. 2016;57:5586-5592.
    PubMed     Text format     Abstract available


  100. BEK T, Jorgensen CM
    The Systemic Blood Pressure and Oxygen Saturation in Retinal Arterioles Predict the Effect of Intravitreal Anti-VEGF Treatment on Diabetic Maculopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5429-5434.
    PubMed     Text format     Abstract available


  101. MISHRA M, Kowluru RA
    The Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5748-5757.
    PubMed     Text format     Abstract available


    September 2016
  102. MAN RE, Fenwick EK, Sabanayagam C, Li LJ, et al
    Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life.
    Invest Ophthalmol Vis Sci. 2016;57:4655-60.
    PubMed     Text format     Abstract available


  103. MCDOWELL RE, McGahon MK, Augustine J, Chen M, et al
    Diabetes Impairs the Aldehyde Detoxifying Capacity of the Retina.
    Invest Ophthalmol Vis Sci. 2016;57:4762-71.
    PubMed     Text format     Abstract available


  104. ZAHID S, Dolz-Marco R, Freund KB, Balaratnasingam C, et al
    Fractal Dimensional Analysis of Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4940-4947.
    PubMed     Text format     Abstract available


  105. TAMAKI K, Usui-Ouchi A, Murakami A, Ebihara N, et al
    Fibrocytes and Fibrovascular Membrane Formation in Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4999-5005.
    PubMed     Text format     Abstract available


    August 2016
  106. JEON SJ, Kwon JW, La TY, Park CK, et al
    Characteristics of Retinal Nerve Fiber Layer Defect in Nonglaucomatous Eyes With Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:4008-4015.
    PubMed     Text format     Abstract available


  107. MISHRA M, Lillvis J, Seyoum B, Kowluru RA, et al
    Peripheral Blood Mitochondrial DNA Damage as a Potential Noninvasive Biomarker of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4035-44.
    PubMed     Text format     Abstract available


  108. LIU H, Tang J, Du Y, Saadane A, et al
    Photoreceptor Cells Influence Retinal Vascular Degeneration in Mouse Models of Retinal Degeneration and Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:4272-81.
    PubMed     Text format     Abstract available


  109. TONADE D, Liu H, Kern TS
    Photoreceptor Cells Produce Inflammatory Mediators That Contribute to Endothelial Cell Death in Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:4264-71.
    PubMed     Text format     Abstract available


  110. LOPES DE FARIA JM, Duarte DA, Montemurro C, Papadimitriou A, et al
    Defective Autophagy in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4356-66.
    PubMed     Text format     Abstract available


    July 2016
  111. KIM AY, Chu Z, Shahidzadeh A, Wang RK, et al
    Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:OCT362-70.
    PubMed     Text format     Abstract available


  112. HASEGAWA N, Nozaki M, Takase N, Yoshida M, et al
    New Insights Into Microaneurysms in the Deep Capillary Plexus Detected by Optical Coherence Tomography Angiography in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2016;57:OCT348-55.
    PubMed     Text format     Abstract available


  113. WANEK J, Blair NP, Chau FY, Lim JI, et al
    Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2016;57:OCT341-7.
    PubMed     Text format     Abstract available


  114. BHANUSHALI D, Anegondi N, Gadde SG, Srinivasan P, et al
    Linking Retinal Microvasculature Features With Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:OCT519-OCT525.
    PubMed     Text format     Abstract available


  115. AL-SHEIKH M, Akil H, Pfau M, Sadda SR, et al
    Swept-Source OCT Angiography Imaging of the Foveal Avascular Zone and Macular Capillary Network Density in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:3907-3913.
    PubMed     Text format     Abstract available


    June 2016
  116. JEONG SY, Park SJ, Chin HS, Kim SH, et al
    Spectral-Domain Optical Coherence Tomography Features in Open-Angle Glaucoma With Diabetes Mellitus and Inadequate Glycemic Control.
    Invest Ophthalmol Vis Sci. 2016;57:3024-31.
    PubMed     Text format     Abstract available


  117. KWON SH, Shin JP, Kim IT, Park DH, et al
    Association of Plasma Semaphorin 3A With Phenotypes of Diabetic Retinopathy and Nephropathy.
    Invest Ophthalmol Vis Sci. 2016;57:2983-9.
    PubMed     Text format     Abstract available


  118. ZHAO M, Hu Y, Yu Y, Lin Q, et al
    Involvement of IL-37 in the Pathogenesis of Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:2955-62.
    PubMed     Text format     Abstract available


  119. AMATO R, Biagioni M, Cammalleri M, Dal Monte M, et al
    VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:3066-76.
    PubMed     Text format     Abstract available


  120. TARCHICK MJ, Bassiri P, Rohwer RM, Samuels IS, et al
    Early Functional and Morphologic Abnormalities in the Diabetic Nyxnob Mouse Retina.
    Invest Ophthalmol Vis Sci. 2016;57:3496-508.
    PubMed     Text format     Abstract available


    May 2016
  121. WANG J, Cui X, Roon P, Smith SB, et al
    Role of Sigma 1 Receptor in Retinal Degeneration of the Ins2Akita/+ Murine Model of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:2770-2781.
    PubMed     Text format     Abstract available


    April 2016
  122. SCHWEITZER C, Korobelnik JF, Boniol M, Cougnard-Gregoire A, et al
    Associations of Biomechanical Properties of the Cornea With Environmental and Metabolic Factors in an Elderly Population: The ALIENOR Study.
    Invest Ophthalmol Vis Sci. 2016;57:2003-2011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: